Precisely what is the relationship between blood
magnesium levels and cardiovascular disease?
Are we describing a progressive magnesium deficiency brought about by
diet deficiency as the epidemiology for cardiovascular disease strongly
indicates? Recall that our salt intake
while high is not from sea salt which provides plenty of magnesium. In fact our natural blood is oceanic and our
cells are supposed to be well bathed in magnesium salts. An imbalance would be unwise but plausible
for land based life such as ourselves.
This article makes the argument for properly
balancing your magnesium levels to suppress cardiovascular disease and the
argument makes sense but we need to see a study confirming this is our core
problem rather than a marginal contributor were few actually have anything
approaching a deficiency.
In the meantime insure your food intake is rich in
magnesium.
And yes this new push on statins is completely
outrageous and bereft of science and commonsense and is clearly driven by the
same corporate greed that even once pretended that cigarettes were good for
you.
Run From Your Statin
Recommending Cardiologist
Matheus on November 19, 2013
There
are new guidelines coming
out of the world of cardiology from the American Heart Association and American
College of Cardiology proving once and for all that cardiologists are idiots or
worse. They simply, en mass, have abandoned their right to call themselves
doctors. I really do not know what to call them but it would be easier to teach
a butcher to practice rational and honorable medicine.
Their
guidelines take aim at preventing strokes and heart attacks. The end result:
twice as many Americans — one-third of all adults — would be told to consider
taking statins, which lower cholesterol but also reduce heart risks in other
ways. "The emphasis is to try to treat more appropriately,"
said Dr. Neil Stone,
the Northwestern University doctor who headed the cholesterol guideline panel.
"We’re going to give statins to those who are the most likely to
benefit."
Under the new advice, one-third of U.S. adults
— 44 percent of men and 22 percent of women — would meet the threshold to
consider taking a statin. Under the current guidelines, statins are recommended
for only about 15 percent of adults. Clearly the doctors and the organization
making these recommendations are marching exactly in the wrong direction and
even worse are seemingly wanting their patients to come down with cancer.
Cardiologists
Disregard Cancer Implications of Statin Use
A
recent study in the journal of Cancer Epidemiology, Biomarkers & Prevention
reports that women who have used cholesterol-lowering statin drugs for more than
10 years have double the risk of two common types of breast
cancer: invasive ductal carcinoma and invasive lobular carcinoma.[1]
One in four Americans take statin drugs, and
the pharmaceutical industry has convinced both patients and doctors that these
drugs will prevent health problems down the road.
Scientists
have long known the toxic effects of statin drugs, and multiple animal studies
have proven an association between statins and various types of cancers.
Experts at the Fred Hutchinson Cancer Research
Centre in Seattle, US, also found the chances
of getting invasive lobular carcinoma, which accounts for ten to 15 per cent
of breast cancers, went up almost 2.5 times in some women on statins long-term.[2]
Published
in the Journal of the American Medical Association (JAMA), Dr. Thomas B. Newman
and co-workers showed that all cholesterol-lowering drugs, both the early drugs
known as fibrates (clofibrate, gemfibrozil) and the newer drugs known as
statins (Lipitor, Pravachol, Zocor), cause cancer in
rodents at the equivalent doses used by man.
Dr.
Gloria Troendle, deputy director for the Division of Metabolism and Endocrine
Drug Products for the FDA, noted that the cholesterol-lowering drug gemfibrozil
belonged to a class of drugs that has repeatedly been shown to increase death rates among users. Moreover, Dr.
Troendle stated that she does not believe the FDA has ever approved a drug for
long-term use that was as cancer causing at human doses as gemfibrozil.
The
Main Effects are the Side Effects
A
significant number of people taking statins (between 3 and 15%) develop mild to
crushing muscle pain that can lead to permanent muscle problems, severe
kidney problems or death.[3]
The drugs can cause severe liver damage, and some recent reports have linked
the use of one statin to neurological and memory problems. Statins cause
reductions in the muscle mitochondrial content of ubiquinone or Coenzyme Q10,
an important part of the ATP-producing electron transport chain that employs
the same precursor molecules as cholesterol.
The mechanism of statin drugs, disruption of
mevalonate synthesis, prevents cells from making compounds that are essential
for healthy cellular life and death. Liver cells begin to accumulate
cholesterol and become distorted, while other cells all over the body lose
their ability to know when it’s time be recycled or to divide. Disrupting
the mevalonate pathway with statin drugs also prevents cells from making CoQ10,
an essential component to energy production. Low CoQ10 results in muscle aches,
muscle injuries, fatigue, and poor cardiac performance. Other statin side
effects include diabetes, liver injury, hormonal imbalance, erectile
dysfunction, depression, memory loss/dementia, and more.
Crestor has the worst side effect profile
among all statin drugs and its approval was initially declined by the FDA. The drug
used in the study, rosuvastatin (brand name Crestor), has been associated with
muscle deterioration and kidney problems. In the study, those taking statins
had a higher risk of developing Type 2 diabetes – 3% compared with 2.4% of
those taking a placebo. That’s a 25% higher relative risk among people with
very little heart disease to begin with.
Statins have also been tied to changes in
memory, concentration and mood, among other problems. Other side effects to
statins include a degenerative muscle disease called myopathy, which can be
fatal. Bayer pulled its statin — Baycol — off the market in August 2001
because it caused too many cases of myopathy. Baycol was linked to 52 deaths
worldwide, including one in Canada.
The
Real Reason to Run From Your Cardiologist
Western medicine’s obsession with cholesterol
misses the boat entirely. The cholesterol heart disease connection that
pharmaceutical companies use to sell billions of dollars of statin drugs is
still largely theoretical, and not clinically borne out in practice whereas the
case of magnesium is scientifically unassailable. The fact that 50% of
people who die from heart attacks do not even have high cholesterol reveals a
gaping hole in medical reasoning and cardiac care.
Magnesium,
not statin drugs, is fundamental for the prevention and treatment of heart
disease, diabetes, and arteriosclerosis; it serves as a
natural calcium antagonist, normalizes blood pressure and irregular heartbeat.
Magnesium is the ultimate heart drug and it is tragic that cardiologists do not
universally acknowledge its full utility in the treatment of heart disease.
An astonishing 40 to 60 percent of sudden
deaths from heart attack may occur in the complete absence of any prior artery
blockage, clot formation or heart rhythm abnormalities, most likely from spasms
in the arteries caused by magnesium deficiency.
Dr. Carolyn Dean
The Miracle of Magnesium.
Administration
of magnesium eliminates angina pain, muscle spasms, keep blood flowing smoothly
and prevent platelet stickiness. Magnesium also produces vasodilation by a
direct action as well indirectly by sympathetic blockade and inhibition of
catecholamine release. Magnesium dilates both the epicardial and resistance
coronary arteries.[4]
Magnesium also balances cholesterol and is essential for endocrine stability
and function. Most importantly – magnesium prevents calcification of the
heart tissues. Medicine
just does not get any better than this. Magnesium is a dream medicine for
cardiologists; its actions include almost everything on a heart specialist’s
wish list.
There is no credible data to show that
lowering LDL numbers with statins actually produces anything similar to the
health benefits of magnesium. The magnesium approach to heart health is
helpful, positive and safe. Using statins on the other hand could cost a person
their life. Lowering LDL too low increases the rate of death.
It is not an exaggeration to say that miracles
in cardiac medicine would be achieved if the overwhelming preponderance of
magnesium deficiency — in adults, adolescents and the very young — were
addressed instead of ignored. Dr. Sarah Myhill states: "There have been
many studies showing that magnesium is clearly beneficial in heart disease. The
trouble is the drug companies do not want to know. Magnesium is a serious
competitor to their moneymaking pharmaceuticals. And so they set up a study
to deliberately blacken the name of magnesium."
Dr.
Duane Graveline, Former USAF Flight Surgeon and NASA Astronaut says, “The fact
that statin drugs are two-edged swords is known to few. It is no wonder doctors
are confused about this class of drugs. When a statin reduces cholesterol,
it is, at the same time, reducing synthesis of CoQ10, dolichols,
selenoproteins, Rho, glutathione and normal phosphorylation by a similar
amount. This, I believe, the cause
of the thousands of side effect reports largely unknown to the medical
community.” [5]
Lowering LDL too low actually increases the rate of death from any one of
several causes.
Vital
Lessons for Cardiologists
In
a study of postoperative ICU patients,[6]
B. Chernow et al. found that the death rate was reduced from 41%
to 13% for patients without hypomagnesemia (low magnesium levels).
Other post-heart-surgery studies showed that patients with hypomagnesemia
experienced more rhythm disorders. Time on the ventilator was longer,[7]
and morbidity was higher than for patients with normal magnesium levels.
Another study showed that a greater than 10% reduction of serum and
intracellular magnesium concentrations was associated with a higher rate of
postoperative ventricular arrhythmias. The administration of magnesium
decreases the frequency of postoperative rhythm disorders after cardiac
surgery.
Clearly, magnesium deficiency is a major risk factor for survival of CHF
patients. In animal experiments, magnesium has been shown to be
involved in several steps of the atherosclerotic process as well as magnesium
ions playing an extremely important role in CHF and various cardiac
arrhythmias.[8]
Magnesium is also required for muscle
relaxation. Lower magnesium levels can result in symptoms ranging from
tachycardia and fibrillation to constriction of the arteries, angina and
instant death.
Due
to lack of magnesium, the heart muscle can develop a spasm or cramp and stop
beating. Most people, including doctors, do not know it but without sufficient
magnesium, we will die. It is more than helpful to understand that our life
span will be reduced if we run too long without sufficient magnesium in our
cells and that the principle way our life is cut short is through cardiac
arrest. Yet when someone dies of a heart attack people never say, “He died from magnesium deficiency.” Allopathic
medicine is designed from the bottom up,[9]
which means it ignores the true causes of death and disease. In the field of
cardiology, this is telling!
Forty
percent of all first heart attacks end in death! One
of the most important actions of magnesium is its vasodilating effects, which
improves the blood supply to ischemic areas and reduces infarct size. A ten-year study of 2,182 men in Wales found that those eating diets low in magnesium had a 50% higher risk of
sudden death from heart attacks than those eating one-third
more magnesium. In addition, high magnesium eaters were only half as likely to have any type of cardiovascular
incident such as non-fatal heart attacks, strokes, angina (chest pain) or heart
surgery.[11]
Pediatricians
Take a Cut of the Action
Many doctors were incredulous about
the aggressive new recommendation from the American Academy of Pediatrics (AAP)
for warding off heart disease in children and for good reason..
In
2008 the AAP recommended wider cholesterol screening for children and more
aggressive use of cholesterol-lowering drugs starting as early as the age of 8
in hopes of preventing adult heart problems.[12]
“What are the data that show this is helpful
preventing heart attacks?” asked Dr. Darshak Sanghavi, a pediatric cardiologist
and assistant professor at the University of Massachusetts Medical School. “How
many heart attacks do we hope to prevent this way? There’s no data regarding
that.” Nor, Dr. Sanghavi added, are there data on the possible side effects of
taking statins for 40 or 50 years.
“To be frank, I’m embarrassed for the A.A.P. today,”
said Dr. Lawrence Rosen of Hackensack University Medical Center in New Jersey,
vice chairman of an academy panel on traditional and alternative medicine. He
added, “Treatment with medications in the absence of any clear data? I
hope they’re ready for the public backlash.” There is no long-term data on
statin use in children. “We’re talking about potentially treating thousands and
thousands of children simply to possibly prevent one heart attack,” says Dr.
Sanghavi, from the University of Massachusetts. “That kind of risk benefit
calculation is entirely absent from the A.A.P.’s policy.”
[1]
Long-term statin use and risk of ductal and lobular breast cancer among women
55-74 years of age; Jean A. McDougall et
al; Cancer Epidemiology, Biomarkers & Prevention; Published Online First July
5, 2013; doi: 10.1158/1055-9965.EPI-13-0414;
[2]
Long-term statin use and risk of ductal and lobular breast cancer among women
55-74 years of age; Jean A. McDougall et
al; Cancer Epidemiology, Biomarkers & Prevention; Published Online First July 5,
2013; doi: 10.1158/1055-9965.EPI-13-0414;
[3]
The problems of statins are not at all insignificant, particularly due to
muscle pain and potentially fatal rhabdomyolysis. The latter condition, while
rare, can cause muscle tissue to break down and release myoglobin, the
oxygen-carrying protein of muscle. Myoglobin release can cause kidney failure
[4]
Heart 2001;86:212-216 ( August ) Magnesium causes nitric oxide
independent coronary artery vasodilation in humans H Teragawa, M Kato, T
Yamagata, H Matsuura, G Kajiyama. The First Department of Internal
Medicine, Hiroshima University School of Medicine
[6]
Hypomagnesemia in patients in postoperative intensive care; Chernow B,
Bamberger S, Stoiko M, et al. CHEST;1989;95(2):391-397.
[7]
England MR, Gordon G, Salem M, Chernow B. Magnesium administration and
dysrhythmias after cardiac surgery. A placebo-controlled, double-blind,
randomized trial. JAMA 1992; 268: 2395–402.
[9]
Since the Rockefellers invaded the medical industry almost 100 years ago we can
see a deliberate pattern engineered into the foundation of medicine. That
engineering was and still is full of hate for human beings meaning it is full
of love of money and power. Whenever you have money interests take the place of
humanitarianism in medicine you produce a form of medicine that hurts and kills
people.
[10]
Am J Epidemiol 1996;143:456–62.
[11]
http://www.mgwater.com/marxneut.shtml
No comments:
Post a Comment